Tff Pharmaceuticals Stock

TFFP 804 003 038 Post-Market 009 112 1711. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions.

Tff Pharmaceuticals Inc Common Stock Tffp Stock Price Quote News History Nasdaq

103 Carlson Capital L P 085 and Renaissance Technologies LLC 072.

Tff pharmaceuticals stock. TFFP a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform today announced that it has priced an underwritten offering of 2855000 shares of its common stock 2140000 shares of which are to be sold by the Company and. When looking into those indicators for TFF Pharmaceuticals Inc. You can view our latest press releases by visiting News Events under the Investors.

Find the latest dividend history for TFF Pharmaceuticals Inc. Learn About Thin. 2001 and Astartein LLC 2013.

23196 Upside Potential This price target is based on 4 analysts offering 12 month price targets for TFF Pharmaceuticals in the last 3 months. Tff Pharmaceuticals Inc NASDAQ Updated Aug 20 2021 1137 PM. 4 Wall Street analysts have issued ratings and price targets for TFF Pharmaceuticals in the last 12 months.

The average price target is 2825 with a high forecast of 3700 and a low forecast of 1800. TFF Pharmaceuticals stock is owned by a number of retail and institutional investors. TFF Pharmaceuticals does not offer a direct stock purchase plan.

Who is TFF Pharmaceuticals legal counsel. Top institutional shareholders include DRW Securities LLC 394 Vanguard Group Inc. Hickey is the founder of three pharmaceutical companies Cirrus Pharmaceuticals Inc.

Company insiders that own TFF Pharmaceuticals stock. Common Stock TFFP Nasdaq Listed. ET by Tomi Kilgore.

TFFP detailed stock quotes stock data Real-Time ECN charts stats and more. He served as Chief Science Officer of Oriel Therapeutics from 2002 to 2007 which was acquired by Sandoz in 2010. TFF Pharmaceuticals Inc.

TFFP stock quote history news and other vital information to help you with your stock trading and investing. Where can I get the latest corporate news releases. TFFP Tff Pharmaceuticals Inc Stock Price and Discussion Stocktwits.

TFF Pharmaceuticals Inc an early-stage biopharmaceutical company focuses on developing and commercializing drug products based on its patented Thin Film Freezing or TFF technology platform in the United States and Australia. 1997 Oriel Therapeutics Inc. -0285 -361 DATA AS OF Aug 17 2021 1212 PM ET.

TFFP investment stock information. Medium term indicators at an average of 100 are spotting the stock at Sell with its 50-day average volume of 172858 shares. The high price target for TFFP is 3700 and the low price target for TFFP is 1800.

Our patented Thin Film Freezing TFF platform makes it possible to turn more molecules into inhalable therapies. The current price level -5076 lower than the highest price of 2114 marked by the stock while trading over the past 52-weeks whereas it is 12244 higher than the lowest price of 468 the company dropped to over past 52-weeks. The Investor Relations website contains information about TFF Pharmaceuticalss business for stockholders potential investors and financial analysts.

This novel technology provides high absorption and yield uniform particle size gentle process and endless possibilities. The average price target represents a. Does TFF Pharmaceuticals have a direct stock purchase plan.

There are currently 4 buy ratings for the stock resulting in a consensus rating of Buy. 11 2021 at 948 am. View Tff Pharmaceuticals Inc.

TFF Pharmaceuticals stock price target raised to 24 from 18 at Maxim Group. TFF Pharmaceuticals Inc. 304 Nantahala Capital Management LLC 145 BlackRock Inc.

Get the latest Tff Pharmaceuticals Inc. Find the latest TFF Pharmaceuticals Inc. Better Delivery Better Therapy With Powerful Inhalable Solutions.

TFFP we notice that the stocks 20-day average volume is at 149770 shares and 50 of short term indicators are suggesting the stock as Sell. The companys lead drug candidates are TFF. He has also served as President and CEO of Cirrus Pharmaceuticals from its founding until its acquisition by Kemwell in 2013.

TFFP saw an uptrend of 1352 in the recent trading with 1041 being its most recent. Data is currently not available. And to end TFFPs 100-day average volume is 212143 shares.

Their average twelve-month price target is 2825 predicting that the stock has a possible upside of 23041. Who is TFF Pharmaceuticals auditor.

Tff Pharmaceuticals Stock Forecast Price News Nasdaq Tffp